Publications

Peer reviewed articles (selected)

  • Hickman-Davis, J.M., O'Reilly, P., Davis, I.C., Peti-Peterdi, J., Davis, G., Young, R., Devlin, R.B., and Matalon, S. (2002). Surfactant protein A- and nitric oxide-mediated mechanisms of Klebsiella pneumoniae killing by human alveolar macrophages. Am. J. Physiol. (Lung Cell. Mol. Physiol.). 282: L944-L956.
  • Davis, I.C., Zajac, A.J., Nolte, K.B., Botten, J., Hjelle, B., and Matalon, S. (2002). Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome. J. Virol. 76: 8347-8359.
  • Davis, I.C., Zhu, S., Sampson, J.B., Crow, J.P., and Matalon, S. (2002). Inhibition of human Surfactant Protein A function by chemically- and enzymatically-catalyzed oxidation intermediates of nitrite. Free Radical Biol. Med.33: 1703-1713.
  • Thome, U., Davis, I.C., Nguyen, S.V., Shelton, B.J., and Matalon, S. (2003). Modulation of sodium transport in fetal alveolar epithelial cells by oxygen and corticosterone. Am. J. Physiol. (Lung Cell. Mol. Physiol.). 284: L376-L385.
  • O'Reilly, P.J., Hickman-Davis, J.M., Davis, I.C., and Matalon, S. (2003). Hyperoxia impairs antibacterial function of macrophages through effects on actin. Am. J. Resp. Cell Mol. Biol. 28: 443-450.
  • Davis, I.C., Sullender, W.M., Hickman-Davis, J.M., Lindsey, J.R., and Matalon, S. (2004). Respiratory syncytial virus inhibits alveolar fluid clearance in BALB/c mice. Am. J. Physiol. (Lung Cell. Mol. Physiol.). 286: L112-L120.
  • Hickman-Davis, J.M., McNicholas-Bevensee, C., Davis, I.C., Davis, G.C., Bosworth, C.A., and Matalon, S. (2005). Reactive oxygen-nitrogen species mediate inhibition of alveolar type II cell sodium transport during mycoplasma infection. Am. J. Resp. Crit. Care Med. 173: 334-344.
  • Davis, I.C., Lazarowski, E.R., Hickman-Davis, J.M., Fortenberry, J.A., Chen, F.-P., Zhao, X., Sorscher, E., Graves, L.M., Sullender, W.M., and Matalon, S. (2005). Leflunomide pretreatment prevents inhibition of alveolar fluid clearance in respiratory syncytial virus-infected BALB/c mice. Am. J. Resp. Crit. Care Med. 173: 673-682.
  • Davis, I.C., Lazarowski, E.R., Chen, F.-P., Sullender, W.M., and Matalon, S. (2006). Post-infection A77-1726 treatment prevents hypoxemia in a mouse model of respiratory syncytial virus infection. J. Virol. Submitted.
  • Davis, I.C., Xu, A., Hickman-Davis, J.M., Factor, P., Sullender, W.M., and Matalon, S. (2006). Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists. Am. J. Resp. Crit. Care Med. Submitted.